What is Gynecologic Cancer?

Gynecologic cancer refers to cancer of the female reproductive system, including ovarian cancer, uterine cancer, cervical cancer, and vulvar cancer. Gynecologic cancer is the fourth most common type of cancer in women, affecting approximately 1 in 20 women. In the United States each year 82,000 women are diagnosed with gynecologic cancer.

Risk Factors of Gynecologic Cancer

Cancer of the Cervix: Molecular and epidemiologic studies have demonstrated a strong relationship between human papillomavirus (HPV), cervical intraepithelial neoplasia (CIN), and invasive carcinomas of the cervix.

Cancers of the Uterine Body: The best-recognized risk factors for the development of the cancer can be related to chronic estrogen exposure. These include oral intake of exogenous estrogen, estrogen-secreting tumors, and low parity.

Ovarian Cancer: In most cases, the exact cause of ovarian cancer remains unknown. The risk of developing ovarian cancer appears to be affected by several factors: genetic mutations, chronic estrogen exposure. The more children a woman have, the lower her risk of ovarian cancer.

Symptoms of Gynecologic Cancer

Cancer of the Cervix, Vagina, and Vulva: The earliest symptom of invasive cervical cancer is usually abnormal vaginal bleeding, often after coitus of vaginal douching. Pain in the pelvis could be symptom.

Cancers of the Uterine Body: Abnormal vaginal bleeding.

Ovarian Cancer: 95% of patients have nonspecific abdominal symptoms.

Diagnosis of Gynecologic Cancer

Cancer of the Cervix, Vagina, and Vulva:  Biopsy is used to diagnose and is an essential step in the diagnosis.

Cancers of the Uterine Body: A diagnosis should be considered in postmenopausal women with any vaginal bleeding, peri-menopausal women with heavy or prolonged bleeding and pre-menopausal women with abnormal bleeding patterns. Outpatient endometrial biopsy leads to the accurate diagnosis.

Ovarian Cancer: Transvaginal ultrasonography (TVS) and abdominal ultrasonography are the most useful diagnostic examinations.

Treatment Options for Gynecologic Cancer at FROS Radiation Oncology Cyberknife Center:

At FROS Radiation Oncology Cyberknife Center, our team is committed to bringing leading-edge technology with highly compassionate care to our patients.

Please call us at 1-888-880-6646 today to find the right treatment for you.




August 28, 2013

June 1, 2013

FROS attending physicians, Alan Katz and Josephine Kang, to give an oral presentation at this year's ASTRO meeting on long term outcomes after stereotactic body radiation therapy (SBRT) for prostate cancer.


The Redefining Radiosurgery Video gives definitive clinical, hospital and patient benefits as compared to other radiation therapy and systems.



Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
Manhattan: 47 Essex St.
New York, NY 10002


Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.